NCT07214376: An ongoing trial by Pulnovo Medical, Inc.
This trial is ongoing. It must report results 4 years, 8 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT07214376 |
|---|---|
| Title | A Randomized Placebo-procedure Controlled Trial of the Multi-Pole Pulmonary Artery Radiofrequency Ablation Enhancor System PULmonary Artery Denervation Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 1, 2026 |
| Completion date | Dec. 31, 2029 |
| Required reporting date | Dec. 31, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |